Drug intelligence / Profile preview

Babao Eye Ointment

Development stage: Unknown
Lead developer: Mayinglong Pharmaceutical
Modality: Small Molecules
Administration: Topical, Ophthalmic

Overview

Babao Eye Ointment (八宝眼膏) is a traditional Chinese medicine (TCM) topical ocular ointment developed and manufactured by Ma Yinglong Pharmaceutical Group. Approved in China under the National Drug Approval Number Z42021455, it is indicated for clearing heat, reducing redness, and relieving itching in eyes that are red, swollen, or teary due to 'wind and fire' according to TCM theory. The formulation is part of the historic Dingzhou eye ointment tradition, which is recognized as a national cultural heritage in China. As a TCM product, it utilizes a combination of herbal and mineral ingredients to achieve its therapeutic effects rather than targeting a specific molecular pathway.

Brand names: Babao Eye Ointment八宝眼膏
Other names: 八宝眼膏Ma Yinglong Babao Eye Ointment

Beyond the preview

Go deeper on Babao Eye Ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Babao Eye Ointment.

Explore the full profile